Drug Trial Radar · NCT01400217
Qvar Versus Clenil, a General Practice Research Database Study
Last checked: Nov 19, 2026Latest source record: Oct 30, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
56,985
Actual
Start
Jan 1991
Primary completion
Oct 2010
Study completion Oct 2010
Sponsor
- Lead sponsor
- Research in Real-Life LtdResearch network
- Sponsor type
- Research network
- Collaborators
- Teva Branded Pharmaceutical Products R&D, Inc.
- First posted
- Jul 22, 2011
Design
- Study type
- Observational
- Who can join
- All sexes, from 4 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will compare the absolute and relative effectiveness of asthma management in patients on inhaled corticosteroid (ICS) maintenance therapy as either extra-fine-particle or larger-particle formulation beclomethasone dipropionate (BDP) via metered-dose inhalers (MDIs) using the propellant hydrofluoroalkane propellant (HFA-BDP), namely Qvar® MDI compared with Clenil® MDI.
Conditions
- Asthma
Interventions
extra fine particle hydrofluoroalkane beclomethasone dipropionate via metered dose inhalerDrug
IPDI cohort intervention = initiation of intervention drug; IPDS cohort intervention = switching from baseline inhaled corticosteroid therapy to intervention drug without a change in baseline inhaled corticosteroid dose; IPDA cohort intervention = increase in baseline inhaled corticosteroid drug as intervention drug
standard particle particle hydrofluoroalkane beclomethasone dipropionate via metered dose inhalerDrug
IPDI cohort intervention = initiation of intervention drug; IPDS cohort intervention = switching from baseline inhaled corticosteroid therapy to intervention drug without a change in baseline inhaled corticosteroid dose; IPDA cohort intervention = increase in baseline inhaled corticosteroid drug as intervention drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Severe asthma exacerbation (ATS/ERS based defn)Time frame: 1 year
- Primary composite asthma controlTime frame: 1 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Research in Real Life Ltd
Cawston, Norfolk, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.